Zacks Investment Management »

Fulcrum Therapeutics shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $61k 21k 2.88
2024-12-31 $99k 21k 4.70